Kosmos Energy Ltd. Prices Upsized Offering of $350 Million 3.125% Convertible Senior Notes Due 2030
DALLAS–(BUSINESS WIRE)–Kosmos Energy Ltd. (NYSE/LSE: KOS) (“Kosmos” or the “Company”), announced today that it has priced a... Read more.
EH Group Gets ‘Approval In Principle’ from DNV for Its 250kW Marine Fuel Cell System
NYON, Switzerland–(BUSINESS WIRE)–#cleantech–EH Group is pleased to announce that its EH Fuel Cell System TRACE-M250, designed for high power and... Read more.
Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which... Read more.
GenSight Biologics Announces Update on Real-World Data from Early Access Programs of LUMEVOQ® Gene Therapy at NANOS 2024
Clinically meaningful improvement in visual acuity confirmed in a real-world setting: on-chart mean visual acuity at 9 months after injection, compared to off-chart... Read more.
Galderma Announces Intention to Float on the SIX Swiss Exchange
ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE... Read more.
Wolters Kluwer wins Best Regulatory Compliance Solution for IFRS 9 at the RegTech Insight APAC Awards
Finance, Risk and Regulatory Reporting’s OneSumX product recognized for its IFRS 9 innovations SINGAPORE–(BUSINESS WIRE)–#ECL–Wolters... Read more.
Nordson Electronics Solutions to Demonstrate Plasma Treatment and Automated Fluid Dispensing Systems for Electronics Manufacturing at SEMICON China 2024
Connect with our experts and see plasma and dispensing equipment for microelectronics manufacturing in booth 3645 CARLSBAD, Calif.–(BUSINESS WIRE)–#nordsonelectronics—Nordson... Read more.
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Phase 1/2 study is evaluating IPH6501, a first-in-class CD20-targeting tetraspecific natural killer cell engager, from ANKET® platform, for the treatment of... Read more.
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
IPH45 abstract selected for oral presentation at AACR Annual Meeting 2024 Preclinical data support further development of IPH45, a differentiated topoisomerase I... Read more.
MCO (MyComplianceOffice) Wins Best eComms Surveillance Solution in the APAC RegTech Insight Awards
SINGAPORE–(BUSINESS WIRE)–#asiarisk–Global compliance technology provider MCO (MyComplianceOffice) has been awarded Best eComms Surveillance Solution... Read more.